People: Roche Holding AG (ROG.VX)

ROG.VX on Virt-X Level 1

19 Dec 2014
Price Change (% chg)

CHF-18.30 (-6.34%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Search Stocks

Humer, Franz 

Brief Biography

Dr. Franz B. Humer has been Non-Executive Chairman of the Board of Directors of Roche Holding AG since March 4, 2008. In addition, he acts as Chairman of the Presidium/Nomination Committee of the Company. From 2001 until March 4, 2008, Dr. Humer served as Chairman of the Corporate Executive Committee and Chief Executive Officer (CEO) at Roche Holding Ltd. From 1971 to 1973, Dr. Humer worked for ICME Zurich. From 1973 until 1981, he worked for Schering Plough Corporation, where he was General Manager in Ecuador, the United Kingdom and Portugal. From 1981 until 1995, Dr. Humer worked for Glaxo Holdings plc as Area Manager, Southern Europe, Director of Marketing Development and Product Licensing, and Chief Operating Director. In 1995, he joined F. Hoffmann-La Roche Ltd as Member of the Board of Directors of the Roche Holding Ltd, Basel, and Head of the Pharmaceuticals Division. In 1996, he became Chief Operating Officer of F. Hoffmann-La Roche Ltd. In 1998, Dr. Humer became CEO Roche Holding Ltd. He is Member of the European Round Table of Industrialists (ERT), Member of the JPMorgan International Council, Board Member of Salzburg University and Member of the Advisory Board at Allianz AG. Furthermore, Dr. Humer occupies the position of Vice Chairman of the International Advisory Board at the International Center for Missing and Exploited Children, Non-Executive Chairman at Diageo Plc and Chairman at Humer Stiftung as well as INSEAD. He holds a Doctorate degree in Law from Universitaet Innsbruck and a Master of Business Administration degree from Institut Europeen d'Administration des Affaires (INSEAD). He also holds an Honorary Doctorate from the Faculty of Science, Universitaet Basel.

Basic Compensation

Total Annual Compensation, CHF Long-Term Incentive Plans, CHF All Other, CHF Fiscal Year Total, CHF
4,000,000 -- 5,158,000 9,158,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Severin Schwan


Fritz Gerber


Franz Humer


Andre Hoffmann


Alan Hippe


Stephan Feldhaus

As Of 30 Dec 2013
Search Stocks